Ophthalmologist Dr Ilan Sebban has become the first surgeon on Sydney’s northern beaches to install Alcon’s Ngenuity 3-D visualisation system.
New data from the five-year HORIZON pivotal trial shows that the Hydrus Microstent (Ivantis) lowers the rate of visual field loss in glaucoma patients
Johnson & Johnson has announced its intention to separate its consumer health business from its pharmaceutical and medical device business, in doing so creating
Optometrists from Australia and New Zealand gathered online in October to attend World Sight Day 2021: #LoveYourEyes, a virtual event presented by Johnson &
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
